Baird Financial Group’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History
Bought
Maintained
Sold
Other funds holding SYNH
CB
Baird Financial Group's SYNH Position: Q3 2022 in Review
Baird Financial Group sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q3 2022, closing a stake of 5,543 shares — an estimated $397K sold.
Baird Financial Group first reported a position in SYNH in Q1 2021 and held it in 6 quarters. The position peaked at $5.12M in Q3 2021. 337 funds tracked by Wall St. Rank hold SYNH as of Q3 2022.
- Baird Financial Group reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q3 2022 after selling out during the quarter.
- Baird Financial Group sold 5,543 Syneos Health, Inc. Class A Common Stock shares in Q3 2022, an estimated $397K.
- Baird Financial Group first reported a position in Syneos Health, Inc. Class A Common Stock in Q1 2021 and held it in 6 quarters.
- Baird Financial Group's Syneos Health, Inc. Class A Common Stock position peaked at $5.12M in Q3 2021.
- 337 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q3 2022.
Based on Baird Financial Group's 13F filing for Q3 2022, filed 15 Nov 2022.